Articles Tagged With:
-
Prepare for Changes to Hazardous Drug Standards
The deadline to adopt new requirements for protecting healthcare workers potentially exposed to hazardous drugs has been extended, giving employee health professionals more time to define their role in medical surveillance and other areas.
-
Employee Health Steps Up in a Rough Flu Season
Employee health professionals stepping up to protect workers and patients during a severe flu season can become part of the outbreak they are trying to prevent.
-
FDA Approves Breast Cancer Gene Home Detection Test
Although it may be a promising advancement, the agency granted its blessing with plenty of caveats.
-
FDA Actions
In this section: The agency approves a new drug for prostate cancer and expands the indication for a non-small cell lung cancer treatment.
-
Influenza A Renders This Year’s Flu Vaccine Ineffective
This year’s flu vaccine was only 36% effective, according to the CDC.
-
What About Aspirin for PCI Patients?
Should clinicians continue using aspirin for patients with prior percutaneous coronary intervention who are undergoing noncardiac surgery? The answer appears to be yes based on the results of a new study from Canada.
-
Comparing Treatments for Cancer-associated VTE
Researchers have determined that edoxaban was noninferior to dalteparin regarding the composite outcome of recurrent VTE or major bleeding, although recurrent VTE was lower and bleeding was higher with edoxaban.
-
Aspirin Matches Xarelto Efficacy Regarding VTE Prophylaxis After Knee or Hip Surgery
The authors of a recent study concluded that among hip or knee arthroplasty patients who receive five days of postoperative rivaroxaban, extended prophylaxis with aspirin was not significantly different from rivaroxaban in the prevention of symptomatic venous thromboembolism.
-
ED Visits for Suspected Opioid Overdoses Skyrocket
A new analysis from the CDC reveals troubling trends across all demographics and regions.
-
Help Us Help You!
Share your expert opinion and help us tailor future articles to meet your professional needs. Please take our reader survey at [link] and tell us which topics intrigue you most.